BioSpace News Archive

Biotech Bay

Pendulum Therapeutics Provides Leadership in Microbiome Education among Healthcare Professionals

Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the microbiome and its relationship to metabolic disease, including type 2 diabetes.

October 28, 2021
·
3 min read
Business

Acutus Medical to Announce Third Quarter 2021 Financial Results

Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today it will release its financial results for the third quarter of 2021 on Thursday, November 11, 2021.

October 28, 2021
·
1 min read
Business

Y-mAbs to Announce Third 2021 Financial and Operating Results on November 4, 2021

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter ended September 30, 2021 on Thursday, November 4, 2021, after the close of the U.S. financial markets.

October 28, 2021
·
4 min read
Business

Lucira Health to Announce Third Quarter 2021 Financial Results

Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced that the company will report third quarter 2021 financial results on, Thursday, November 11, 2021.

October 28, 2021
·
1 min read
Business

Miromatrix to Report Third Quarter 2021 Financial Results

Miromatrix Medical Inc., a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that the Company will report financial results for the third quarter 2021 after market close on Monday, November 15, 2021.

October 28, 2021
·
1 min read
Business

Aravive Reports Third Quarter 2021 Financial Results and Provides Corporate Updates

Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative, targeted therapeutics to treat life-threatening cancers, today announced recent corporate updates and financial results for the third quarter ended September 30, 2021.

October 28, 2021
·
12 min read
Business

Iridex to Report Third Quarter 2021 Financial Results on November 11, 2021

Iridex Corporation, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced the Company will release financial results for the third quarter of 2021 after the close of trading on Thursday, November 11, 2021.

October 28, 2021
·
1 min read
Business

Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results on November 9, 2021

Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today announced that it will report financial results for the third quarter of 2021 after the market close on Tuesday, November 9, 2021.

October 28, 2021
·
1 min read
Business

Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress

Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its third quarter 2021 financial results and provided a corporate update.

October 28, 2021
·
22 min read
Drug Development

Additional Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Published in the Annals of Oncology

Today, overall survival (OS) data from Eli Lilly and Company’s (NYSE: LLY) Verzenio® (abemaciclib) Phase 3 monarchE study were published in a Letter to the Editor in the Annals of Oncology.

October 28, 2021
·
19 min read